Skip to content

KnobbeMedical.com

Boston Scientific Agrees to Acquire SoniVie Ltd. for up to $540 Million

March 18, 2025  | Wentao Wu

Advancing Science for Life - US - Boston ScientificHome - SoniVie

Boston Scientific recently announced it entered into a definitive agreement to acquire SoniVie Ltd.  According to the press release, SoniVie is a privately held medical device company that developed the TIVUS Intravascular Ultrasound System.

SoniVie describes TIVUS as an intravascular, catheter-based technology that performs denervation of nerves surrounding the blood vessels (including renal artery denervation) to treat hypertensive disorders.  Inceased sympathetic nerve activity between the kidneys and brain sometimes results in elevated blood pressure.  TIVUS reduces blood pressure by disrupting that nerve activity with ultrasonic energy, causing blood vessels to relax and safely lowering blood pressure.

Commenting on the agreement, Lance Bates, Boston Scientific’s SVP and President of Interventional Cardiology Therapies, said “Renal denervation for hypertension is an exciting medical advancement for the millions of patients it may help and is supported by positive results from contemporary clinical trials and ongoing research.”  Bates continued that Boston Scientific believes “the addition of the ultrasound-based TIVUS system can complement their expansive interventional portfolio with a minimally invasive therapy for patients with hypertension.”

The deal is expected to close in the first half of 2025 and is valued at approximately $540 million.  The agreement to acquire involves Boston Scientific paying about $360 million for the 90% of SoniVie’s equity that Boston Scientific does not already own, plus up to an additional $180 million payment if SoniVie achieves a regulatory milestone.

Boston Scientific’s press release is available here.

Tags

, , , , ,

Boston Scientific Agrees to Acquire SoniVie Ltd. for up to $540 Million Headshot

Wentao Wu

Wentao Wu is an associate in the firm’s San Francisco office. Wentao helps clients with a variety of intellectual property matters with a focus on patent prosecution in electrical and electronics engineering, computer science and software technology, semiconductors, optics, advanced materials, and other areas of physics and engineering.

Wentao received her J.D. from the University of California, Davis School of Law, where she earned a Business Law Certificate and an Intellectual Property Law Certificate. During law school, she also served as a Senior Articles Editor for the UC Davis Business Law Journal.

Before attending law school, Wentao received her B.S. in Physics from Fudan University and her M.S. in Electrical Engineering from Columbia University. She also worked as an associate patent agent at a patent law firm in China.

Wentao worked as a summer associate with the firm in 2023 and joined the firm in 2024.

View all posts published by Wentao Wu
By using this blog, you agree and understand that no information is being provided in the context of any attorney-client relationship. You further agree and understand that nothing herein is intended to be legal advice. This blog is solely informational in nature, and is not intended as, and should not be used as, a substitute for competent legal advice from a retained and licensed attorney in your state. Knobbe Martens LLP makes no representations or warranties as to the accuracy, completeness, timeliness or availability of the information in this blog. Knobbe Martens LLP will not be liable for any injury or damages relating to your use of, or access to, any such information. Knobbe Martens LLP undertakes no obligation to correct or update information on this blog, which may be incorrect or become incorrect or out of date over time. Knobbe Martens LLP reserves the right to alter or delete content or information on the blog at any time. This blog contains links and references to other websites and publications that you may find of interest. Knobbe Martens LLP does not control, promote, endorse or otherwise have any affiliation with any other websites or publications unless those websites or publications expressly state such an affiliation. Knobbe Martens LLP further has no responsibility for, and makes no representations regarding, the content, accuracy or any other aspect of the information in such websites or publications.
close modal